Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study

Identification of new molecular markers to enhance early diagnosis, prognosis and/or treatment of hepatocellular carcinoma (HCC) is a need. TOM34 (34 kDa-translocase of the outer mitochondrial membrane) protein expression deregulation has demonstrated to be involved in the growth of many cancers. He...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical biochemistry 2019-01, Vol.63, p.10-17
Hauptverfasser: Toraih, Eman A., Alrefai, Hani G., Hussein, Mohammad H., Helal, Ghada M., Khashana, Moataz S., Fawzy, Manal S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 17
container_issue
container_start_page 10
container_title Clinical biochemistry
container_volume 63
creator Toraih, Eman A.
Alrefai, Hani G.
Hussein, Mohammad H.
Helal, Ghada M.
Khashana, Moataz S.
Fawzy, Manal S.
description Identification of new molecular markers to enhance early diagnosis, prognosis and/or treatment of hepatocellular carcinoma (HCC) is a need. TOM34 (34 kDa-translocase of the outer mitochondrial membrane) protein expression deregulation has demonstrated to be involved in the growth of many cancers. Here, we aimed at evaluating serum TOM34 and some heat shock proteins (HSPA4, HSPA1B, and HSP90AA1) expressions in hepatitis C virus (HCV)-related cirrhosis and HCV-induced HCC relative to controls and correlating these expressions to the clinicopathological data. Serum specimens were collected from 90 patients with HCV associated complications (30 cirrhotic, 30 early HCC and 30 late HCC) and 60 controls. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed for relative quantification of the four target genes using the Livak method. In silico network analysis was also executed to explore the contribution of the genes in liver cancer. The serum TOM34 and HSP90AA1 transcripts were significantly upregulated in HCC patients compared to cirrhotic ones with more up-regulation in late HCC patients. Receiver operating characteristic analysis showed the optimum cutoff value of 0.625 corresponding to 71.7% sensitivity and 56.7% specificity, and an area under the curve (AUC) of 0.705 to discriminate HCC from cirrhotic groups (P = .002). In multivariate analysis, ordination plot showed obvious demarcation between the study groups caused by the higher levels of TOM34 among other variables. TOM34 and its partner HSP90AA1 might be used as a potential biomarker for monitoring HCV-induced HCC progression in the Egyptian population. Future large-scale validation studies are warranted. •HCC is associated with a significant TOM34 and its partner HSP90AA1 overexpression.•TOM34 monitoring could be a potential biomarker for early detection of HCC.•HSP90AA1 could be a good discriminator for late HCC.•Heat shock and chaperon genes showed sex-related differential expression.
doi_str_mv 10.1016/j.clinbiochem.2018.12.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2155145854</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009912018308798</els_id><sourcerecordid>2155145854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-aee3497b4aa542335a9bc8b5484e9e89028e750b70f490102217868ad8b31f703</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS0EokPhFZDZsUnw78RmNxoBrVQ0SBS2luPcaDwkcbCdir4Mz4qjaRFLVleWvnvPOT4IvaGkpoRu351qN_ip9cEdYawZoaqmrCaEPkEbqhpeMc35U7QhhOhKU0Yu0IuUTuXJhNo-RxecSEYbTTfo9-EOIvyaI6Tkw4RDj49gM07H4H7gOYYMfsJXX79osttRbKcO52inNARnE6x4PpaxZIh49Lk4ClMXvR3wCGNbSMC3h89c4PXK_nvlp25x0BWR2RYahmEZbMTORuenMNr3eIdnP4TiIC_d_Uv0rLdDglcP8xJ9-_jhdn9V3Rw-Xe93N5XjTZMrC8CFblphrRSMc2l161QrhRKgQWnCFDSStA3phSaUsJJebZXtVMtp3xB-id6e75bEPxdI2Yw-re5KgLAkw6iUVEglRUH1GXUxpBShN3P0o433hhKz1mNO5p96zFqPocyUesru6weZpR2h-7v52EcB9mcAStg7D9Ek52EqP-YjuGy64P9D5g-pGqfP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2155145854</pqid></control><display><type>article</type><title>Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Toraih, Eman A. ; Alrefai, Hani G. ; Hussein, Mohammad H. ; Helal, Ghada M. ; Khashana, Moataz S. ; Fawzy, Manal S.</creator><creatorcontrib>Toraih, Eman A. ; Alrefai, Hani G. ; Hussein, Mohammad H. ; Helal, Ghada M. ; Khashana, Moataz S. ; Fawzy, Manal S.</creatorcontrib><description>Identification of new molecular markers to enhance early diagnosis, prognosis and/or treatment of hepatocellular carcinoma (HCC) is a need. TOM34 (34 kDa-translocase of the outer mitochondrial membrane) protein expression deregulation has demonstrated to be involved in the growth of many cancers. Here, we aimed at evaluating serum TOM34 and some heat shock proteins (HSPA4, HSPA1B, and HSP90AA1) expressions in hepatitis C virus (HCV)-related cirrhosis and HCV-induced HCC relative to controls and correlating these expressions to the clinicopathological data. Serum specimens were collected from 90 patients with HCV associated complications (30 cirrhotic, 30 early HCC and 30 late HCC) and 60 controls. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed for relative quantification of the four target genes using the Livak method. In silico network analysis was also executed to explore the contribution of the genes in liver cancer. The serum TOM34 and HSP90AA1 transcripts were significantly upregulated in HCC patients compared to cirrhotic ones with more up-regulation in late HCC patients. Receiver operating characteristic analysis showed the optimum cutoff value of 0.625 corresponding to 71.7% sensitivity and 56.7% specificity, and an area under the curve (AUC) of 0.705 to discriminate HCC from cirrhotic groups (P = .002). In multivariate analysis, ordination plot showed obvious demarcation between the study groups caused by the higher levels of TOM34 among other variables. TOM34 and its partner HSP90AA1 might be used as a potential biomarker for monitoring HCV-induced HCC progression in the Egyptian population. Future large-scale validation studies are warranted. •HCC is associated with a significant TOM34 and its partner HSP90AA1 overexpression.•TOM34 monitoring could be a potential biomarker for early detection of HCC.•HSP90AA1 could be a good discriminator for late HCC.•Heat shock and chaperon genes showed sex-related differential expression.</description><identifier>ISSN: 0009-9120</identifier><identifier>EISSN: 1873-2933</identifier><identifier>DOI: 10.1016/j.clinbiochem.2018.12.001</identifier><identifier>PMID: 30521791</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Biomarkers, Tumor - blood ; Carcinoma, Hepatocellular - blood ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - virology ; Female ; Gene Expression Regulation, Neoplastic ; Hepacivirus ; Hepatitis C - blood ; Hepatitis C - pathology ; Hepatocellular Carcinoma ; HSP90 Heat-Shock Proteins - blood ; HSP90AA1 ; HSPA1B ; HSPA4 ; Humans ; Liver Neoplasms - blood ; Liver Neoplasms - pathology ; Liver Neoplasms - virology ; Male ; Middle Aged ; Mitochondrial Membrane Transport Proteins - blood ; Neoplasm Proteins - blood ; Pilot Projects ; Real-Time Polymerase Chain Reaction ; TOM34</subject><ispartof>Clinical biochemistry, 2019-01, Vol.63, p.10-17</ispartof><rights>2018 The Canadian Society of Clinical Chemists</rights><rights>Copyright © 2018 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-aee3497b4aa542335a9bc8b5484e9e89028e750b70f490102217868ad8b31f703</citedby><cites>FETCH-LOGICAL-c377t-aee3497b4aa542335a9bc8b5484e9e89028e750b70f490102217868ad8b31f703</cites><orcidid>0000-0003-1252-8403</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0009912018308798$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30521791$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toraih, Eman A.</creatorcontrib><creatorcontrib>Alrefai, Hani G.</creatorcontrib><creatorcontrib>Hussein, Mohammad H.</creatorcontrib><creatorcontrib>Helal, Ghada M.</creatorcontrib><creatorcontrib>Khashana, Moataz S.</creatorcontrib><creatorcontrib>Fawzy, Manal S.</creatorcontrib><title>Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study</title><title>Clinical biochemistry</title><addtitle>Clin Biochem</addtitle><description>Identification of new molecular markers to enhance early diagnosis, prognosis and/or treatment of hepatocellular carcinoma (HCC) is a need. TOM34 (34 kDa-translocase of the outer mitochondrial membrane) protein expression deregulation has demonstrated to be involved in the growth of many cancers. Here, we aimed at evaluating serum TOM34 and some heat shock proteins (HSPA4, HSPA1B, and HSP90AA1) expressions in hepatitis C virus (HCV)-related cirrhosis and HCV-induced HCC relative to controls and correlating these expressions to the clinicopathological data. Serum specimens were collected from 90 patients with HCV associated complications (30 cirrhotic, 30 early HCC and 30 late HCC) and 60 controls. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed for relative quantification of the four target genes using the Livak method. In silico network analysis was also executed to explore the contribution of the genes in liver cancer. The serum TOM34 and HSP90AA1 transcripts were significantly upregulated in HCC patients compared to cirrhotic ones with more up-regulation in late HCC patients. Receiver operating characteristic analysis showed the optimum cutoff value of 0.625 corresponding to 71.7% sensitivity and 56.7% specificity, and an area under the curve (AUC) of 0.705 to discriminate HCC from cirrhotic groups (P = .002). In multivariate analysis, ordination plot showed obvious demarcation between the study groups caused by the higher levels of TOM34 among other variables. TOM34 and its partner HSP90AA1 might be used as a potential biomarker for monitoring HCV-induced HCC progression in the Egyptian population. Future large-scale validation studies are warranted. •HCC is associated with a significant TOM34 and its partner HSP90AA1 overexpression.•TOM34 monitoring could be a potential biomarker for early detection of HCC.•HSP90AA1 could be a good discriminator for late HCC.•Heat shock and chaperon genes showed sex-related differential expression.</description><subject>Adult</subject><subject>Biomarkers, Tumor - blood</subject><subject>Carcinoma, Hepatocellular - blood</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - virology</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hepacivirus</subject><subject>Hepatitis C - blood</subject><subject>Hepatitis C - pathology</subject><subject>Hepatocellular Carcinoma</subject><subject>HSP90 Heat-Shock Proteins - blood</subject><subject>HSP90AA1</subject><subject>HSPA1B</subject><subject>HSPA4</subject><subject>Humans</subject><subject>Liver Neoplasms - blood</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - virology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mitochondrial Membrane Transport Proteins - blood</subject><subject>Neoplasm Proteins - blood</subject><subject>Pilot Projects</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>TOM34</subject><issn>0009-9120</issn><issn>1873-2933</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhS0EokPhFZDZsUnw78RmNxoBrVQ0SBS2luPcaDwkcbCdir4Mz4qjaRFLVleWvnvPOT4IvaGkpoRu351qN_ip9cEdYawZoaqmrCaEPkEbqhpeMc35U7QhhOhKU0Yu0IuUTuXJhNo-RxecSEYbTTfo9-EOIvyaI6Tkw4RDj49gM07H4H7gOYYMfsJXX79osttRbKcO52inNARnE6x4PpaxZIh49Lk4ClMXvR3wCGNbSMC3h89c4PXK_nvlp25x0BWR2RYahmEZbMTORuenMNr3eIdnP4TiIC_d_Uv0rLdDglcP8xJ9-_jhdn9V3Rw-Xe93N5XjTZMrC8CFblphrRSMc2l161QrhRKgQWnCFDSStA3phSaUsJJebZXtVMtp3xB-id6e75bEPxdI2Yw-re5KgLAkw6iUVEglRUH1GXUxpBShN3P0o433hhKz1mNO5p96zFqPocyUesru6weZpR2h-7v52EcB9mcAStg7D9Ek52EqP-YjuGy64P9D5g-pGqfP</recordid><startdate>201901</startdate><enddate>201901</enddate><creator>Toraih, Eman A.</creator><creator>Alrefai, Hani G.</creator><creator>Hussein, Mohammad H.</creator><creator>Helal, Ghada M.</creator><creator>Khashana, Moataz S.</creator><creator>Fawzy, Manal S.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1252-8403</orcidid></search><sort><creationdate>201901</creationdate><title>Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study</title><author>Toraih, Eman A. ; Alrefai, Hani G. ; Hussein, Mohammad H. ; Helal, Ghada M. ; Khashana, Moataz S. ; Fawzy, Manal S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-aee3497b4aa542335a9bc8b5484e9e89028e750b70f490102217868ad8b31f703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Biomarkers, Tumor - blood</topic><topic>Carcinoma, Hepatocellular - blood</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - virology</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hepacivirus</topic><topic>Hepatitis C - blood</topic><topic>Hepatitis C - pathology</topic><topic>Hepatocellular Carcinoma</topic><topic>HSP90 Heat-Shock Proteins - blood</topic><topic>HSP90AA1</topic><topic>HSPA1B</topic><topic>HSPA4</topic><topic>Humans</topic><topic>Liver Neoplasms - blood</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - virology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mitochondrial Membrane Transport Proteins - blood</topic><topic>Neoplasm Proteins - blood</topic><topic>Pilot Projects</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>TOM34</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toraih, Eman A.</creatorcontrib><creatorcontrib>Alrefai, Hani G.</creatorcontrib><creatorcontrib>Hussein, Mohammad H.</creatorcontrib><creatorcontrib>Helal, Ghada M.</creatorcontrib><creatorcontrib>Khashana, Moataz S.</creatorcontrib><creatorcontrib>Fawzy, Manal S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toraih, Eman A.</au><au>Alrefai, Hani G.</au><au>Hussein, Mohammad H.</au><au>Helal, Ghada M.</au><au>Khashana, Moataz S.</au><au>Fawzy, Manal S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study</atitle><jtitle>Clinical biochemistry</jtitle><addtitle>Clin Biochem</addtitle><date>2019-01</date><risdate>2019</risdate><volume>63</volume><spage>10</spage><epage>17</epage><pages>10-17</pages><issn>0009-9120</issn><eissn>1873-2933</eissn><abstract>Identification of new molecular markers to enhance early diagnosis, prognosis and/or treatment of hepatocellular carcinoma (HCC) is a need. TOM34 (34 kDa-translocase of the outer mitochondrial membrane) protein expression deregulation has demonstrated to be involved in the growth of many cancers. Here, we aimed at evaluating serum TOM34 and some heat shock proteins (HSPA4, HSPA1B, and HSP90AA1) expressions in hepatitis C virus (HCV)-related cirrhosis and HCV-induced HCC relative to controls and correlating these expressions to the clinicopathological data. Serum specimens were collected from 90 patients with HCV associated complications (30 cirrhotic, 30 early HCC and 30 late HCC) and 60 controls. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed for relative quantification of the four target genes using the Livak method. In silico network analysis was also executed to explore the contribution of the genes in liver cancer. The serum TOM34 and HSP90AA1 transcripts were significantly upregulated in HCC patients compared to cirrhotic ones with more up-regulation in late HCC patients. Receiver operating characteristic analysis showed the optimum cutoff value of 0.625 corresponding to 71.7% sensitivity and 56.7% specificity, and an area under the curve (AUC) of 0.705 to discriminate HCC from cirrhotic groups (P = .002). In multivariate analysis, ordination plot showed obvious demarcation between the study groups caused by the higher levels of TOM34 among other variables. TOM34 and its partner HSP90AA1 might be used as a potential biomarker for monitoring HCV-induced HCC progression in the Egyptian population. Future large-scale validation studies are warranted. •HCC is associated with a significant TOM34 and its partner HSP90AA1 overexpression.•TOM34 monitoring could be a potential biomarker for early detection of HCC.•HSP90AA1 could be a good discriminator for late HCC.•Heat shock and chaperon genes showed sex-related differential expression.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30521791</pmid><doi>10.1016/j.clinbiochem.2018.12.001</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1252-8403</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0009-9120
ispartof Clinical biochemistry, 2019-01, Vol.63, p.10-17
issn 0009-9120
1873-2933
language eng
recordid cdi_proquest_miscellaneous_2155145854
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Biomarkers, Tumor - blood
Carcinoma, Hepatocellular - blood
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - virology
Female
Gene Expression Regulation, Neoplastic
Hepacivirus
Hepatitis C - blood
Hepatitis C - pathology
Hepatocellular Carcinoma
HSP90 Heat-Shock Proteins - blood
HSP90AA1
HSPA1B
HSPA4
Humans
Liver Neoplasms - blood
Liver Neoplasms - pathology
Liver Neoplasms - virology
Male
Middle Aged
Mitochondrial Membrane Transport Proteins - blood
Neoplasm Proteins - blood
Pilot Projects
Real-Time Polymerase Chain Reaction
TOM34
title Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T23%3A26%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overexpression%20of%20heat%20shock%20protein%20HSP90AA1%20and%20translocase%20of%20the%20outer%20mitochondrial%20membrane%20TOM34%20in%20HCV-induced%20hepatocellular%20carcinoma:%20A%20pilot%20study&rft.jtitle=Clinical%20biochemistry&rft.au=Toraih,%20Eman%20A.&rft.date=2019-01&rft.volume=63&rft.spage=10&rft.epage=17&rft.pages=10-17&rft.issn=0009-9120&rft.eissn=1873-2933&rft_id=info:doi/10.1016/j.clinbiochem.2018.12.001&rft_dat=%3Cproquest_cross%3E2155145854%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2155145854&rft_id=info:pmid/30521791&rft_els_id=S0009912018308798&rfr_iscdi=true